These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5029384)

  • 21. Short- and long-term regulation of tyrosine hydroxylase.
    Costa E; Guidotti A; Zivkovic B
    Adv Biochem Psychopharmacol; 1974; 12(0):161-75. PubMed ID: 4154019
    [No Abstract]   [Full Text] [Related]  

  • 22. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.
    Stadler H; Lloyd KG; Gadea-Ciria M; Bartholini G
    Brain Res; 1973 Jun; 55(2):476-80. PubMed ID: 4351628
    [No Abstract]   [Full Text] [Related]  

  • 23. Influence of drugs on catecholamine metabolism in brain as studied by 14C-tyrosine.
    Nybäck H; Sedvall G
    Br J Pharmacol; 1968 Sep; 34(1):220P-221P. PubMed ID: 5676022
    [No Abstract]   [Full Text] [Related]  

  • 24. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 25. Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine.
    Nybäck H; Sedvall G
    Eur J Pharmacol; 1969 Feb; 5(3):245-52. PubMed ID: 5772674
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of 3,4-dihydroxyphenylacetic acid on catecholamines and serotonin in rat striatum.
    Yamada K; Minnich J; Donaldson J; Barbeau A
    J Neurol Sci; 1973 Mar; 18(3):311-5. PubMed ID: 4698311
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of phencyclidine on the accumulation of 14 C-catecholamines formed from 14 C-tyrosine.
    Hitzemann RJ; Loh HH; Domino EF
    Arch Int Pharmacodyn Ther; 1973 Apr; 202(2):252-8. PubMed ID: 4694363
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dopamine metabolism in structures of the striato-nigral system during elaboration of conditioned avoidance reflexes in rats].
    Saul'skaia NB; Chivileva OG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(5):1083-5. PubMed ID: 6797145
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopamine and noradrenaline transport into subcellular vesicles of the striatum.
    Philippu A; Beyer J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(4):387-402. PubMed ID: 4269971
    [No Abstract]   [Full Text] [Related]  

  • 30. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
    Zivkovic B; Guidotti A; Revuelta A; Costa E
    J Pharmacol Exp Ther; 1975 Jul; 194(1):37-46. PubMed ID: 239221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
    Ohashi T; Akita H; Tamura T; Noda K; Honda F
    Arzneimittelforschung; 1972 Jun; 22(6):966-72. PubMed ID: 5068358
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum.
    Walters JR; Roth RH
    Biochem Pharmacol; 1972 Aug; 21(15):2111-21. PubMed ID: 4645883
    [No Abstract]   [Full Text] [Related]  

  • 35. Mapping neuronal activity of the basal ganglia in experimental models of Parkinson's disease: contributions of the [14C]2-deoxyglucose method.
    Orzi F; Fornai F; Blandini F
    Funct Neurol; 2000; 15(4):269-76. PubMed ID: 11213530
    [No Abstract]   [Full Text] [Related]  

  • 36. INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.
    POIRIER LJ; SOURKES TL
    Brain; 1965 Mar; 88():181-92. PubMed ID: 14280273
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat.
    Agid Y; Javoy F; Glowinski J
    Nat New Biol; 1973 Oct; 245(144):150-1. PubMed ID: 4517903
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction between cholinergic and catecholaminergic neurones in rat brain.
    Corrodi H; Fuxe K; Lidbrink P
    Brain Res; 1972 Aug; 43(2):397-416. PubMed ID: 4403347
    [No Abstract]   [Full Text] [Related]  

  • 39. Accelerated synthesis of dopamine-C14 from tyrosine-C14 in rat brain after chlorpromazine.
    Nybäck H; Sedvall G; Kopin IJ
    Life Sci; 1967 Nov; 6(21):2307-12. PubMed ID: 6060277
    [No Abstract]   [Full Text] [Related]  

  • 40. [INFLUENCE OF LOCUS NIGER ON THE CONCENTRATION OF CATECHOLAMINES IN THE STRIATUM].
    POIRIER LJ; SOURKES TL
    J Physiol (Paris); 1964; 56():426-7. PubMed ID: 14219844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.